Chromium Picolinate Improves Insulin Sensitivity In Obese Subjects With Polycystic Ovary Syndrome
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 5 |
| Sex | Female |
| Age Range | 18-29 |
| Body Types | Overweight |
In five women with PCOS, supplementation of 470mcg chromium (as picolinate) twice daily for two months appeared to improve insulin sensitivity as assessed by glucose disposal rates, but no other parameter was significantly improved; insulin was nonsignificantly reduced.
